Table 4. Changes in the Visual Analog Scale and Kujala Patellofemoral Scale scores of the groups at the end of week 6 and week 12.
Group 1 | Group 2 | Group 3 | ||||
Median | Min-Max | Median | Min-Max | Median | Min-Max | |
Visual Analog Scale | ||||||
(0-100 mm) | ||||||
Before treatment | 40 | 20-70 | 50 | 30-80 | 50 | 20-80 |
6th week | 30 | 0-50 | 20 | 0-40 | 20 | 0-40 |
12th week | 40 | 0-60 | 30 | 0-60 | 30 | 10-50 |
c2 | 43,934 | 44,273 | 45,916 | |||
p | p<0.001 | p<0.001 | p<0.001 | |||
Kujala Patellofemoral Scale | ||||||
(0-100) | ||||||
Before treatment | 84 | 70-91 | 85 | 72-96 | 84 | 67-91 |
6th week | 87 | 74-100 | 89 | 81-100 | 87 | 82-94 |
12th week | 87 | 74-96 | 88 | 76-98 | 86 | 76-92 |
c2 | 39,609 | 42,944 | 42,000 | |||
p | p<0.001 | p<0.001 | p<0.001 | |||
Min: Minimum; Max: Maximum; Change 1: Before treatment - 6th week; Change 2: Before treatment - c2: 12th week; Chi‐square. |